Idera Pharmaceuticals Current Ratio 2006-2021 | IDRA

Idera Pharmaceuticals current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Idera Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.04B $0.01B 7.21
2021-03-31 $0.05B $0.01B 9.41
2020-12-31 $0.04B $0.01B 5.89
2020-09-30 $0.03B $0.01B 4.59
2020-06-30 $0.03B $0.01B 4.47
2020-03-31 $0.04B $0.03B 1.05
2019-12-31 $0.05B $0.06B 0.85
2019-09-30 $0.05B $0.01B 5.80
2019-06-30 $0.05B $0.01B 8.19
2019-03-31 $0.06B $0.01B 9.82
2018-12-31 $0.07B $0.01B 8.07
2018-09-30 $0.09B $0.01B 8.25
2018-06-30 $0.10B $0.01B 6.96
2018-03-31 $0.11B $0.01B 8.88
2017-12-31 $0.12B $0.01B 11.54
2017-09-30 $0.07B $0.01B 8.83
2017-06-30 $0.08B $0.01B 11.08
2017-03-31 $0.10B $0.01B 13.63
2016-12-31 $0.11B $0.01B 11.87
2016-09-30 $0.06B $0.01B 7.06
2016-06-30 $0.07B $0.01B 9.14
2016-03-31 $0.07B $0.01B 12.76
2015-12-31 $0.06B $0.01B 9.28
2015-09-30 $0.07B $0.01B 11.98
2015-06-30 $0.08B $0.01B 11.89
2015-03-31 $0.12B $0.01B 18.76
2014-12-31 $0.04B $0.01B 6.02
2014-09-30 $0.06B $0.01B 8.81
2014-06-30 $0.07B $0.01B 10.34
2014-03-31 $0.07B $0.01B 13.41
2013-12-31 $0.03B $0.00B 6.87
2013-09-30 $0.04B $0.00B 16.05
2013-06-30 $0.02B $0.00B 5.56
2013-03-31 $0.01B $0.00B 1.55
2012-12-31 $0.01B $0.00B 2.49
2012-09-30 $0.01B $0.00B 2.00
2012-06-30 $0.01B $0.01B 2.80
2012-03-31 $0.02B $0.01B 3.45
2011-12-31 $0.03B $0.01B 4.08
2011-09-30 $0.02B $0.00B 5.44
2011-06-30 $0.02B $0.00B 6.65
2011-03-31 $0.03B $0.00B 8.50
2010-12-31 $0.04B $0.00B 10.07
2010-09-30 $0.05B $0.01B 5.99
2010-06-30 $0.04B $0.01B 4.34
2010-03-31 $0.04B $0.01B 3.86
2009-12-31 $0.04B $0.01B 2.62
2009-09-30 $0.05B $0.02B 2.27
2009-06-30 $0.05B $0.03B 2.10
2009-03-31 $0.05B $0.03B 2.10
2008-12-31 $0.06B $0.03B 2.29
2008-09-30 $0.06B $0.03B 2.37
2008-06-30 $0.06B $0.03B 2.32
2008-03-31 $0.06B $0.03B 2.39
2007-12-31 $0.03B $0.01B 2.74
2007-09-30 $0.03B $0.01B 3.19
2007-06-30 $0.03B $0.01B 3.42
2007-03-31 $0.04B $0.01B 4.15
2006-12-31 $0.04B $0.01B 4.86
2006-09-30 $0.01B $0.00B 2.30
2006-06-30 $0.01B $0.01B 2.05
2006-03-31 $0.01B $0.01B 3.05
2005-12-31 $0.01B $0.00B 2.23
2005-09-30 $0.01B $0.00B 3.39
2005-06-30 $0.02B $0.00B 4.53
2005-03-31 $0.01B $0.00B 6.77
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.046B $0.001B
Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera's proprietary drug candidates are designed to modulate Toll-like Receptors, the body's first line of immune defense. Idera's pioneering DNA chemistry expertise enables it to identify drug candidates for internal development and creates opportunities for multiple collaborative alliances.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76